INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 48m ago
HOUSE PTR7m ago
SEC 13F7m ago
ROBINHOOD CHAIN7m ago
Public company

VTGNVistagen Therapeutics, Inc.

CIK 0001411685

EDGAR filingsOpen in network
Disclosed transactions8
Buys / sells0 / 0
Max Insider Score15
Connections6with evidence

VTGN · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
AS
Angelov Angel SChief Medical Officer
VTGNVistagen Therapeutics, Inc.
Grant or award
A—
150.0K sh
May 18, 2026May 19, 2026
traded May 18, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Angelov Angel SChief Medical Officer · May 19, 2026
  • ← Insider ofevidence
    Cote Elissa S.Chief Corp Development Officer · Apr 9, 2026
  • ← Insider ofevidence
    Prince Joshua S.Chief Operating Officer · Apr 9, 2026
9
CS
Cote Elissa S.Chief Corp Development Officer
VTGNVistagen Therapeutics, Inc.
Grant or award
A
—
75.0K sh
Apr 7, 2026
Apr 9, 2026
traded Apr 7, 2026
+2d
SEC FORM 4

Evidence

9
AG
Adler Reid G.Chief Legal Officer
VTGNVistagen Therapeutics, Inc.
Grant or award
A—
18.8K sh
Apr 7, 2026Apr 9, 2026
traded Apr 7, 2026
+2dSEC FORM 4

Evidence

9
AG
Adler Reid G.Chief Legal Officer
VTGNVistagen Therapeutics, Inc.
Grant or award
A—
56.2K sh
Apr 7, 2026Apr 9, 2026
traded Apr 7, 2026
+2dSEC FORM 4

Evidence

9
TB
Tressler Nick B.Chief Financial Officer
VTGNVistagen Therapeutics, Inc.
Grant or award
A—
75.0K sh
Apr 7, 2026Apr 9, 2026
traded Apr 7, 2026
+2dSEC FORM 4

Evidence

9
PS
Prince Joshua S.Chief Operating Officer
VTGNVistagen Therapeutics, Inc.
Grant or award
A—
56.2K sh
Apr 7, 2026Apr 9, 2026
traded Apr 7, 2026
+2dSEC FORM 4

Evidence

9
PS
Prince Joshua S.Chief Operating Officer
VTGNVistagen Therapeutics, Inc.
Grant or award
A—
18.8K sh
Apr 7, 2026Apr 9, 2026
traded Apr 7, 2026
+2dSEC FORM 4

Evidence

15
TB
Tressler Nick B.Chief Financial Officer
VTGNVistagen Therapeutics, Inc.
Grant or award
A—
150.0K sh
Dec 1, 2025Dec 4, 2025
traded Dec 1, 2025
+3dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Adler Reid G.Chief Legal Officer · Apr 9, 2026
  • ← Insider ofevidence
    Tressler Nick B.Chief Financial Officer · Dec 4, 2025